Cytovale: Leveraging Partner Authority to Dominate Industry Narratives and Gain Market Advantage
For growth-stage healthcare companies, inclusion in industry trend stories and national conversations signals market credibility – and directly drives commercial momentum. Yet many find themselves on the sidelines, wondering why a competitor was featured instead. The difference often comes down to consistent storytelling, trusted relationships, and strategic positioning.
​
To ensure Cytovale was consistently visible where it mattered most, we executed a precision PR program that combined trade credibility with high-profile exposure. We targeted the hospital and clinical laboratory publications their buyers read most, pairing proactive pitching of company milestones – including published studies and customer wins – with thought leadership authored by Cytovale KOLs and leading clinicians from partner hospitals. This deliberate strategy leveraged partner authority to deepen credibility and maintain a steady drumbeat of meaningful coverage.
​
The result: Cytovale’s narrative became consistent, authoritative, and frequently led industry trend features – often ahead of competitors. The halo of partner alignment strengthened trust with media and influencers, while the company’s growing visibility unlocked new recognition and invitations to premier stages such as the Forbes Healthcare Summit and prestigious industry awards such as Modern Healthcare’s Best in Business.​
Highlights
​
​Media coverage​​ included:
-
"Sepsis Causes Over 350,000 Deaths Annually. This Lab Test Can Reduce That By A Third," Forbes
-
"Cytovale gains momentum with $100M for its sepsis screening test," FierceBiotech
-
"Rapid Host Response Test Boosts ED Discharge Rates and Hospital-Free Days," Medscape
-
"Taming a Toxic Threat: New AI tools send lifesaving alerts on sepsis," WebMD
-
"Why Hospital EDs Are Adopting Cytovale’s Sepsis Test," MedCityNews
​
Awards
Theresa and her team are nothing short of amazing and have been great partners of mine as we tackle the world of sepsis.
​Shaun Walsh
Cytovale, VP of Enterprise Marketing​




